AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference Pharmaceutical Investing
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism Pharmaceutical Investing
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025 Pharmaceutical Investing
Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
ABVC BioPharma Receives $450,000 in Licensing Payments From OncoX BioPharma in Q3 2025 Pharmaceutical Investing
Invion CEO Maps Path to Peer-level Valuation as Momentum for Cancer Treatment Trials Builds Pharmaceutical Investing
Entera Bio to Unveil Clinical and Non-Clinical Data Across 3 Oral Peptide Programs at Upcoming September Conferences Pharmaceutical Investing
Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 Pharmaceutical Investing
